![Warnex and Rosetta Genomics Announce Exclusive Distribution Agreement for Rosetta's microRNA-Based Assays in Canada | Technology Networks Warnex and Rosetta Genomics Announce Exclusive Distribution Agreement for Rosetta's microRNA-Based Assays in Canada | Technology Networks](https://assets.technologynetworks.com/production/dynamic/images/content/default/default-960x540.jpg?cb=5063563)
Warnex and Rosetta Genomics Announce Exclusive Distribution Agreement for Rosetta's microRNA-Based Assays in Canada | Technology Networks
Ronen Tamir email address & phone number | Pfizer Senior Director and Team Leader Global Competitive Intelligence, Portfolio and Decision Analysis contact information - RocketReach
![Vaccines | Free Full-Text | Rapidly Establishing an Ultra-Cold Supply Chain of Vaccines in Israel: Evidence for the Efficacy of Inoculation to Mitigate the COVID-19 Pandemic Vaccines | Free Full-Text | Rapidly Establishing an Ultra-Cold Supply Chain of Vaccines in Israel: Evidence for the Efficacy of Inoculation to Mitigate the COVID-19 Pandemic](https://pub.mdpi-res.com/vaccines/vaccines-11-00349/article_deploy/html/images/vaccines-11-00349-g008.png?1675412641)
Vaccines | Free Full-Text | Rapidly Establishing an Ultra-Cold Supply Chain of Vaccines in Israel: Evidence for the Efficacy of Inoculation to Mitigate the COVID-19 Pandemic
![Vaccines | Free Full-Text | Rapidly Establishing an Ultra-Cold Supply Chain of Vaccines in Israel: Evidence for the Efficacy of Inoculation to Mitigate the COVID-19 Pandemic Vaccines | Free Full-Text | Rapidly Establishing an Ultra-Cold Supply Chain of Vaccines in Israel: Evidence for the Efficacy of Inoculation to Mitigate the COVID-19 Pandemic](https://www.mdpi.com/vaccines/vaccines-11-00349/article_deploy/html/images/vaccines-11-00349-g001a.png)
Vaccines | Free Full-Text | Rapidly Establishing an Ultra-Cold Supply Chain of Vaccines in Israel: Evidence for the Efficacy of Inoculation to Mitigate the COVID-19 Pandemic
Design of SARS-CoV-2 hFc-Conjugated Receptor-Binding Domain mRNA Vaccine Delivered via Lipid Nanoparticles | ACS Nano
![Design of SARS-CoV-2 hFc-Conjugated Receptor-Binding Domain mRNA Vaccine Delivered via Lipid Nanoparticles | ACS Nano Design of SARS-CoV-2 hFc-Conjugated Receptor-Binding Domain mRNA Vaccine Delivered via Lipid Nanoparticles | ACS Nano](https://pubs.acs.org/cms/10.1021/acsnano.0c10180/asset/images/large/nn0c10180_0001.jpeg)